Wang Shanshan, Chen Xuejun, Han Xiaolu, Hong Xiaoxuan, Li Xiang, Zhang Hui, Li Meng, Wang Zengming, Zheng Aiping
College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Pharmaceutics. 2023 Jan 26;15(2):416. doi: 10.3390/pharmaceutics15020416.
Three-dimensional printing technology, also called additive manufacturing technology, is used to prepare personalized 3D-printed drugs through computer-aided model design. In recent years, the use of 3D printing technology in the pharmaceutical field has become increasingly sophisticated. In addition to the successful commercialization of Spritam in 2015, there has been a succession of Triastek's 3D-printed drug applications that have received investigational new drug (IND) approval from the Food and Drug Administration (FDA). Compared with traditional drug preparation processes, 3D printing technology has significant advantages in personalized drug manufacturing, allowing easy manufacturing of preparations with complex structures or drug release behaviors and rapid manufacturing of small batches of drugs. This review summaries the mechanisms of the most commonly used 3D printing technologies, describes their characteristics, advantages, disadvantages, and applications in the pharmaceutical industry, analyzes the progress of global commercialization of 3D printed drugs and their problems and challenges, reflects the development trends of the 3D printed drug industry, and guides researchers engaged in 3D printed drugs.
三维打印技术,也称为增材制造技术,用于通过计算机辅助模型设计来制备个性化的3D打印药物。近年来,3D打印技术在制药领域的应用越来越成熟。除了2015年Spritam成功商业化外,Triastek还有一系列3D打印药物应用获得了美国食品药品监督管理局(FDA)的研究性新药(IND)批准。与传统药物制备工艺相比,3D打印技术在个性化药物制造方面具有显著优势,能够轻松制造具有复杂结构或药物释放行为的制剂,并能快速制造小批量药物。本文综述总结了最常用的3D打印技术的机制,描述了它们的特点、优点、缺点以及在制药行业的应用,分析了3D打印药物全球商业化的进展及其存在的问题和挑战,反映了3D打印药物行业的发展趋势,并为从事3D打印药物研究的人员提供指导。